While the RARE Drug Development Symposium may have taken on a different form this year, the presence of the rare community was more palpable than ever. You showed up from all over the world, at every level of patient advocacy and research. Two days of jam-packed drug development programming featured rare disease patients, advocates, and researchers. We learned how to navigate foundation-industry partnerships, the importance of repurposing drug treatments, and strategies for diversifying clinical trials. Here’s a breakdown of the event: